NCT04703374

A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects

A Randomized, Open-label, Crossover Phase 1 Clinical Trial to Compare Pharmaciokinetics, Pharmacodynamics and Safetry After Single/ Multiple Administration of CKD-382 and D026 in Healthy Subjects

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

To compare pharmacokinetics, pharmacodynamics and safety after single/multiple administration of CKD-382 and D026 in healthy subjects

Detailed description

A randomized, open-label, crossover phase 1 clinical trial to compare pharmacokinetics, pharmacodynamics and safety after single / multiple administration of CKD-382 and D026 in healthy subjects

Conditions

• GERD

Interventions

Type	Name	Description
DRUG	CKD-382(formulation I)	1 tablet administered under fasting condition for 7days
DRUG	CKD-382(formulation II)	1 tablet administered under fasting condition for 7days
DRUG	D026	1 tablet administered under fasting condition for 7days

Timeline

• Start date: 2020-09-25
• Primary completion: 2021-09-01
• Completion: 2021-09-01
• First posted: 2021-01-11
• Last updated: 2021-01-11

Locations

1 site across 1 country: South Korea